Cartesian Therapeutics board member Murat Kalayoglu resigns effective March 31, 2026

Cartesian Therapeutics, Inc.

Director Murat Kalayoglu, M.D., Ph.D. resigned from board effective March 31, 2026 to pursue other opportunities.
He served as Chairman of Science and Technology Committee and on Nominating and Corporate Governance Committee.
Resignation not due to any disagreement with the company on operations, policies, or practices.
Kalayoglu had been on board since 2023; no replacement announced.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001453687-26-000068
form_type: 8-K
ticker: RNAC
cik: 0001453687
company_name: Cartesian Therapeutics, Inc.
filed_at: 2026-03-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.113106+00:00
generated_at: 2026-05-15T08:21:41.428418+00:00
sec_items: ["5.02"]
event_type: leadership
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001453687-26-000068
json_url: https://secwatch.observer/filing/0001453687-26-000068.json
markdown_url: https://secwatch.observer/filing/0001453687-26-000068.md
text_url: https://secwatch.observer/filing/0001453687-26-000068.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000068/0001453687-26-000068-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368726000068/rnac-20260326.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001453687-26-000068

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.